Sepio Capital, LP Inmune Bio, Inc. Transaction History

Sepio Capital, LP

  • $1.03 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 03, 2023
SELL
$6.13 - $7.96 $7,356 - $9,552
-1,200 Reduced 4.92%
23,200 $147,000
Q3 2022

Oct 28, 2022
BUY
$6.04 - $10.44 $14,496 - $25,056
2,400 Added 10.91%
24,400 $151,000
Q2 2022

Jul 26, 2022
BUY
$5.48 - $8.97 $120,560 - $197,340
22,000 New
22,000 $194,000

Others Institutions Holding INMB

# of Institutions
70
Shares Held
5.88M
Call Options Held
243K
Put Options Held
46.4K
View Full List

About Inmune Bio, Inc.

INMB Quotes by TradingView
  • Ticker INMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,946,000
  • Market Cap $89M
  • Description
  • INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...
More about INMB
Track This Portfolio

Track Sepio Capital, LP Portfolio

Follow Sepio Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sepio Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Sepio Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email